Literature DB >> 20635879

Implication of human endogenous retroviruses in the development of autoimmune diseases.

Eva Balada1, Miquel Vilardell-Tarrés, Josep Ordi-Ros.   

Abstract

Retroviruses can exist in an endogenous form, in which viral sequences are integrated into the human germ line and are vertically transmitted in a Mendelian fashion. Human endogenous retroviruses (HERVs), probably representing footprints of ancient germ-cell retroviral infections, occupy about 1% of the human genome. Some HERVs emerged in the genome over 25 million years ago, while others have appeared rather recently, at about the time of hominid and ape lineages divergence. Although some of these elements show mutations and deletions, some HERVs are transcriptionally active and produce functional proteins. Some medical conditions, such as cancer and autoimmune diseases, are linked to the transcription of some of the HERVs genes, to the expression of HERVs proteins (that may act as superantigens, for example), and/or to the development of antibodies against them that might cross-react with our own proteins. Their genetic sequences may also be, totally or partially, integrated into genes that regulate the immune response. These mechanisms could give rise to autoimmune diseases, such as lupus erythematosus, insulin-dependent diabetes mellitus, multiple sclerosis, Sjögren's syndrome, and rheumatoid arthritis, among others. This review is aimed at discussing evidence for a possible role of HERVs in the etiopathogenesis of different autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635879     DOI: 10.3109/08830185.2010.485333

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  44 in total

1.  Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?

Authors:  Caroline Jefferies; Claire Wynne; Rowan Higgs
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

2.  Initiating type I diabetes: new suspects in the lineup.

Authors:  Rémi J Creusot
Journal:  Nat Med       Date:  2013-01       Impact factor: 53.440

3.  TLR7 induces anergy in human CD4(+) T cells.

Authors:  Margarita Dominguez-Villar; Anne-Sophie Gautron; Marine de Marcken; Marla J Keller; David A Hafler
Journal:  Nat Immunol       Date:  2014-11-17       Impact factor: 25.606

4.  Genomic flexibility of human endogenous retrovirus type K.

Authors:  Derek Dube; Rafael Contreras-Galindo; Shirley He; Steven R King; Marta J Gonzalez-Hernandez; Scott D Gitlin; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

5.  Polymorphic integrations of an endogenous gammaretrovirus in the mule deer genome.

Authors:  Daniel Elleder; Oekyung Kim; Abinash Padhi; Jason G Bankert; Ivan Simeonov; Stephan C Schuster; Nicola E Wittekindt; Susanne Motameny; Mary Poss
Journal:  J Virol       Date:  2011-12-21       Impact factor: 5.103

6.  Molecular mechanism for p202-mediated specific inhibition of AIM2 inflammasome activation.

Authors:  Qian Yin; David P Sester; Yuan Tian; Yu-Shan Hsiao; Alvin Lu; Jasmyn A Cridland; Vitaliya Sagulenko; Sara J Thygesen; Divaker Choubey; Veit Hornung; Thomas Walz; Katryn J Stacey; Hao Wu
Journal:  Cell Rep       Date:  2013-07-11       Impact factor: 9.423

7.  Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.

Authors:  G Mameli; G L Erre; E Caggiu; S Mura; D Cossu; M Bo; M L Cadoni; A Piras; N Mundula; E Colombo; G Buscetta; G Passiu; L A Sechi
Journal:  Clin Exp Immunol       Date:  2017-05-09       Impact factor: 4.330

8.  Identification of human endogenous retrovirus transcripts in Hodgkin Lymphoma cells.

Authors:  Marie Barth; Victoria Gröger; Holger Cynis; Martin Sebastian Staege
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

9.  Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins.

Authors:  Kenny L De Meirleir; Svetlana F Khaiboullina; Marc Frémont; Jan Hulstaert; Albert A Rizvanov; András Palotás; Vincent C Lombardi
Journal:  In Vivo       Date:  2013 Mar-Apr       Impact factor: 2.155

Review 10.  Retroviruses and amyotrophic lateral sclerosis.

Authors:  Tariq Alfahad; Avindra Nath
Journal:  Antiviral Res       Date:  2013-05-23       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.